ANCORAHEART.COM: Keyword Density Checker

Total words: 1029 | 2-word phrases: 267 | 3-word phrases: 286 | 4-word phrases: 294

PAGE INFO

Title	Try to keep the title under 60 characters (66 characters) Heart Failure Treatment Options and Clinical Trials \| Ancora Heart
Description	Try to keep the meta description between 50 - 160 characters (153 characters) Ancora Heart, a medical device company, has developed AccuCinch®, the first percutaneous ventricular restoration system designed to treat heart failure.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (4 characters) Home

#	Keyword	Frequency	Density
1	the accucinch ventricular	2	0.70%
2	of the accucinch	2	0.70%
3	accucinch ventricular restoration	2	0.70%
4	with heart failure	2	0.70%
5	limited by united	2	0.70%
6	by united states	2	0.70%
7	united states law	2	0.70%
8	states law to	2	0.70%
9	of heart failure	2	0.70%
10	quality of life	2	0.70%
11	ventricular restoration system	2	0.70%
12	physicians clinical studies	2	0.70%
13	patients physicians clinical	2	0.70%
14	clinical evidence early	1	0.35%
15	a randomized controlled	1	0.35%
16	ejection fraction hfref	1	0.35%
17	we are currently	1	0.35%
18	are currently enrolling	1	0.35%
19	currently enrolling patients	1	0.35%
20	enrolling patients in	1	0.35%
21	patients in a	1	0.35%
22	heart ancora heart	1	0.35%
23	be a good	1	0.35%
24	in a randomized	1	0.35%
25	may be a	1	0.35%
26	with reduced ejection	1	0.35%
27	clinical trial called	1	0.35%
28	trial called the	1	0.35%
29	called the corcinchhf	1	0.35%
30	the corcinchhf study	1	0.35%

#	Keyword	Frequency	Density
1	the accucinch ventricular restoration	2	0.68%
2	patients physicians clinical studies	2	0.68%
3	united states law to	2	0.68%
4	by united states law	2	0.68%
5	limited by united states	2	0.68%
6	ancora heart ancora heart	1	0.34%
7	with reduced ejection fraction	1	0.34%
8	initiate a process of	1	0.34%
9	a process of reverse	1	0.34%
10	process of reverse remodeling	1	0.34%
11	of reverse remodeling in	1	0.34%
12	patients who have heart	1	0.34%
13	who have heart failure	1	0.34%
14	have heart failure with	1	0.34%
15	heart failure with reduced	1	0.34%
16	failure with reduced ejection	1	0.34%
17	we are currently enrolling	1	0.34%
18	reduced ejection fraction hfref	1	0.34%
19	capacity and initiate a	1	0.34%
20	are currently enrolling patients	1	0.34%
21	currently enrolling patients in	1	0.34%
22	enrolling patients in a	1	0.34%
23	patients in a randomized	1	0.34%
24	in a randomized controlled	1	0.34%
25	clinical trial called the	1	0.34%
26	trial called the corcinchhf	1	0.34%
27	called the corcinchhf study	1	0.34%
28	the corcinchhf study to	1	0.34%
29	corcinchhf study to further	1	0.34%
30	study to further evaluate	1	0.34%
31	and initiate a process	1	0.34%
32	functional capacity and initiate	1	0.34%
33	benefits of the accucinch	1	0.34%
34	heart ancora heart patients	1	0.34%
35	breathing or memory loss	1	0.34%
36	or memory loss and	1	0.34%
37	memory loss and have	1	0.34%
38	loss and have exhausted	1	0.34%
39	and have exhausted other	1	0.34%
40	treatments the accucinch ventricular	1	0.34%

#	URL	Whois	Check
1	https://www.fda.gov/medical-devices/how-study-and-market-your-device/breakthrough-devices-program#s1	Whois	fda.gov
2	https://www.youtube.com/watch?v=g9MoRe_1tBY	Whois	youtube.com
3	https://www.youtube.com/watch?v=_VHXN4I9-7g	Whois	youtube.com
4	https://youtu.be/lP1Hex0webI	Whois	youtu.be
5	https://youtu.be/NiStBh-ICeo	Whois	youtu.be
6	https://youtu.be/SlskBTG0VEA	Whois	youtu.be
7	https://www.youtube.com/watch?v=NZjtaxrddM4	Whois	youtube.com